Advertisement

Topics

Ricerca Biosciences LLC Company Profile

06:50 EDT 19th June 2018 | BioPortfolio

Ricerca Biosciences' integrated drug discovery service model is the only one in North America that can take hit compounds, then utilize medicinal chemistry coupled with ADMET to optimize those hits either at Ricerca or cost-effectively via our synthetic chemistry partnership, and take your compound deep into preclinical toxicology (in vivo), and then to an IND.Our process chemistry group and pilot plant are capable of making a drug candidate efficiently and scaleable for Phase I and early Phase II testing. These activities are supported by our extensive analytical services to assure the quality of material being used is acceptable to government regulations and patient safety. While Ricerca has value as a "one-stop-shopping" model for early drug discovery companies, a company at any stage in its drug development program can make use of Ricerca's numerous capabilities.
Finally, Ricerca has the external connections to smoothly and seamlessly transfer information to one of our manufacturing partners once a product is ready for Phase III trials. Our aim is to be the conduit for taking our clients' solutions from the drawing board to clinical trials.

Location

7528 Auburn Road, P.O. Box 1000
Concord
Ohio
44077-1000
United States of America

Contact

Phone: 888.742.3722 or 888.763.4797
Fax: 440.357.4939
Email: info@ricerca.com


News Articles [636 Associated News Articles listed on BioPortfolio]

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...

SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

Kuros Biosciences Ltd.: Kuros Biosciences weitet Lizenzabkommen mit Checkmate aus

Schlieren (Zürich), Schweiz, 8. Januar 2018 Kuros Biosciences weitet Lizenzabkommen mit Checkmate aus Kuros Biosciences AG (SIX: KURN) gibt die Ausdehnung des exklusiven Lizenzabkommens mit Checkm...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women...

Apricus Biosciences, Inc.: Apricus Biosciences Announces Proposed Public Offering

SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that ...

Ricerca Biosciences LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummaryRicerca Biosciences LLC Ricerca, formerly Ricerca Inc, a subsidiary of Main Market Partners LLC, is a contract research organization that offers services to accelerate drug development. The org...

Ricerca Biosciences LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28112017] Prices from USD $250

SummaryRicerca Biosciences LLC Ricerca, formerly Ricerca Inc, a subsidiary of Main Market Partners LLC, is a contract research organization that offers services to accelerate drug development. The org...

Apricus Biosciences, Inc.: Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros

Company Evaluating Deficiencies and Potential Path Forward SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative me...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic

The purpose of the expanded access program is to allow physicians to provide treatment with investigational drug, AB-PA01, for patients with serious or immediately life-threatening Pseudom...

Companies [356 Associated Companies listed on BioPortfolio]

Ricerca Biosciences, LLC

Ricerca Biosciences offers a comprehensive suite of discovery and preclinical services to support drug candidates from discovery through IND on a global scale, including ca...

Ricerca Biosciences LLC

Ricerca Biosciences' integrated drug discovery service model is the only one in North America that can take hit compounds, then utilize medicinal chemistry coupled with ADMET to optimize those hits ei...

Grünenthal

Grünenthal è una società farmaceutica indipendente, basata sulla ricerca con operazioni internazionali. E' sempre stata una società a capitale privato fin dalla sua fondazione nel 1946. I prodotti...

Ufficio Ricerca Internazionale

NIL

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

More Information about "Ricerca Biosciences LLC" on BioPortfolio

We have published hundreds of Ricerca Biosciences LLC news stories on BioPortfolio along with dozens of Ricerca Biosciences LLC Clinical Trials and PubMed Articles about Ricerca Biosciences LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ricerca Biosciences LLC Companies in our database. You can also find out about relevant Ricerca Biosciences LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record